PreDxion Bio Company
PreDxion Bio aims to revolutionize critical care medicine by providing ICU doctors with actionable patient immune function data
Headquarters:
Others
Total Funding:
$120K
Founded Date:
2016-02-02
Investors Number:
3
Estimated Revenue:
Less than $1M
Investor Type:
For Profit
Technology:
Other
Employee Number:
1-10
Industry:
P4 Medicine
Last Funding Type:
Seed
Funding Status:
Seed